BCL2 and cancer: When including the cancer type as an additional feature for each cell line, SuperDendrix identifies a total of 227 differential dependencies that are associated with sets of mutations and/or cancer-type features, most prominently dependencies on lineage-specific transcription factors and a previously unreported association between TCF3 dependency and myeloma or blood cancers with mutations in BCL2.